BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 29369411)

  • 1. Safety and efficacy of epicutaneous immunotherapy for food allergy.
    Wang J; Sampson HA
    Pediatr Allergy Immunol; 2018 Jun; 29(4):341-349. PubMed ID: 29369411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.
    Lanser BJ; Leung DYM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):153-161. PubMed ID: 29081025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for Food Allergy: Are We There Yet?
    Gernez Y; Nowak-Węgrzyn A
    J Allergy Clin Immunol Pract; 2017; 5(2):250-272. PubMed ID: 28283151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicutaneous peanut patch device for the treatment of peanut allergy.
    Langlois A; Graham F; Bégin P
    Expert Rev Clin Immunol; 2019 May; 15(5):449-460. PubMed ID: 30864861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicutaneous immunotherapy induces gastrointestinal LAP
    Tordesillas L; Mondoulet L; Blazquez AB; Benhamou PH; Sampson HA; Berin MC
    J Allergy Clin Immunol; 2017 Jan; 139(1):189-201.e4. PubMed ID: 27417020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional Therapies for the Treatment of Food Allergy.
    Parrish CP; Kim EH; Bird JA
    Immunol Allergy Clin North Am; 2018 Feb; 38(1):77-88. PubMed ID: 29132676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration.
    Chiang D; Berin MC
    Curr Allergy Asthma Rep; 2015 Jun; 15(6):35. PubMed ID: 26141581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual and Patch Immunotherapy for Food Allergy.
    Waldron J; Kim EH
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):135-148. PubMed ID: 31761114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicutaneous immunotherapy: the next step for food allergy desensitization.
    De Jong NW
    Expert Rev Clin Immunol; 2018 Dec; 14(12):977-978. PubMed ID: 30295101
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
    Fleischer DM; Shreffler WG; Campbell DE; Green TD; Anvari S; Assa'ad A; Bégin P; Beyer K; Bird JA; Brown-Whitehorn T; Byrne A; Chan ES; Cheema A; Chinthrajah S; Chong HJ; Davis CM; Ford LS; Gagnon R; Greenhawt M; Hourihane JO; Jones SM; Kim EH; Lange L; Lanser BJ; Leonard S; Mahler V; Maronna A; Nowak-Wegrzyn A; Oriel RC; O'Sullivan M; Petroni D; Pongracic JA; Prescott SL; Schneider LC; Smith P; Staab D; Sussman G; Wood R; Yang WH; Lambert R; Peillon A; Bois T; Sampson HA
    J Allergy Clin Immunol; 2020 Oct; 146(4):863-874. PubMed ID: 32659313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.
    Mondoulet L; Dioszeghy V; Ligouis M; Dhelft V; Dupont C; Benhamou PH
    Clin Exp Allergy; 2010 Apr; 40(4):659-67. PubMed ID: 20002446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy and Safety of Epicutaneous Immunotherapy for Allergic Diseases: A Systematic Review and Meta-Analysis.
    Xiong L; Lin J; Luo Y; Chen W; Dai J
    Int Arch Allergy Immunol; 2020; 181(3):170-182. PubMed ID: 31801149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Skin to Solution: Exploring Epicutaneous Immunotherapy for Peanut Allergy-A Systematic Review and Meta-Analysis.
    Banatwala UESS; Nasir MM; Javed R; Ahmed A; Farhan SA; Ajam A
    Clin Rev Allergy Immunol; 2024 Apr; 66(2):125-137. PubMed ID: 38526693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Status of Potential Therapies for IgE-Mediated Food Allergy.
    Parrish CP; Har D; Andrew Bird J
    Curr Allergy Asthma Rep; 2018 Feb; 18(3):18. PubMed ID: 29470658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.
    Dupont C; Burks AW; Fleischer DM; Bee KJ; Chainani S; Sampson HA
    Expert Rev Clin Immunol; 2024 Jun; 20(6):623-633. PubMed ID: 38323337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy - risk/benefit in food allergy.
    Kostadinova AI; Willemsen LE; Knippels LM; Garssen J
    Pediatr Allergy Immunol; 2013 Nov; 24(7):633-44. PubMed ID: 24112425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Treatment of Food Allergy: Sublingual and Epicutaneous Immunotherapy.
    Sindher S; Fleischer DM; Spergel JM
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):39-54. PubMed ID: 26617226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy.
    Liu G; Liu M; Wang J; Mou Y; Che H
    Front Immunol; 2021; 12():660974. PubMed ID: 34305893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food Allergy Immunotherapy with Adjuvants.
    Nicolaides RE; Parrish CP; Bird JA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):149-173. PubMed ID: 31761115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted allergen-specific immunotherapy within the skin improves allergen delivery to induce desensitization to peanut.
    Landers JJ; Janczak KW; Shakya AK; Zarnitsyn V; Patel SR; Baker JR; Gill HS; O'Konek JJ
    Immunotherapy; 2022 May; 14(7):539-552. PubMed ID: 35196877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.